Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2015

Ausgabe 2/2015

Inhaltsverzeichnis ( 26 Artikel )

01.01.2015 | Review | Ausgabe 2/2015

Infection risk in breast cancer patients treated with trastuzumab: a systematic review and meta-analysis

Tomohiro Funakoshi, Maya Suzuki, Hyman B. Muss

01.01.2015 | Review | Ausgabe 2/2015

Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors

Shirley M. Bluethmann, Sally W. Vernon, Kelley Pettee Gabriel, Caitlin C. Murphy, L. Kay Bartholomew

01.01.2015 | Preclinical study | Ausgabe 2/2015

The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer

Jan J. Jobsen, Job van der Palen, Mariël Brinkhuis, Johan W. R. Nortier, Henk Struikmans

01.01.2015 | Preclinical Study | Ausgabe 2/2015 Open Access

Biological and clinical significance of PARP1 protein expression in breast cancer

Andrew R. Green, Daniela Caracappa, Ahmed A. Benhasouna, Alaa Alshareeda, Christopher C. Nolan, R. Douglas Macmillan, Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha

01.01.2015 | Preclinical study | Ausgabe 2/2015

INPP4B and RAD50 have an interactive effect on survival after breast cancer

Xiaofeng Dai, Rainer Fagerholm, Sofia Khan, Carl Blomqvist, Heli Nevanlinna

01.01.2015 | Preclinical study | Ausgabe 2/2015

A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib

N. Elster, M. Cremona, C. Morgan, S. Toomey, A. Carr, A. O’Grady, B. T. Hennessy, A. J. Eustace

01.01.2015 | Preclinical Study | Ausgabe 2/2015

Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients

C. Benitez-Buelga, L. Sanchez-Barroso, M. Gallardo, María Apellániz-Ruiz, L. Inglada-Pérez, K. Yanowski, J. Carrillo, L. Garcia-Estevez, I. Calvo, R. Perona, M. Urioste, A. Osorio, M. A. Blasco, C. Rodriguez-Antona, J. Benitez

01.01.2015 | Preclinical Study | Ausgabe 2/2015

C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast

Junjun Liu, Xiaozhen Liu, Xiaolong Feng, Jian Liu, Shuhua Lv, Wei Zhang, Yun Niu

01.01.2015 | Preclinical study | Ausgabe 2/2015

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

Yanchun Li, Jocelyn C. Reader, Xinrong Ma, Namita Kundu, Tyler Kochel, Amy M. Fulton

01.01.2015 | Preclinical study | Ausgabe 2/2015

Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated

Mitra Noroozian, Lauren F. Stein, Kara Gaetke-Udager, Mark A. Helvie

01.01.2015 | Preclinical Study | Ausgabe 2/2015 Open Access

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy

Adam D. Pfefferle, Benjamin T. Spike, Geoff M. Wahl, Charles M. Perou

01.01.2015 | Clinical Trial | Ausgabe 2/2015

Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial

Shuzhen Liu, Judy-Anne W. Chapman, Margot J. Burnell, Mark N. Levine, Kathleen I. Pritchard, Timothy J. Whelan, Hope S. Rugo, Kathy S. Albain, Edith A. Perez, Shakeel Virk, Garrett Barry, Dongxia Gao, Patti O’Brien, Lois E. Shepherd, Torsten O. Nielsen, Karen A. Gelmon

01.01.2015 | Clinical trial | Ausgabe 2/2015

Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial

Claudia M. Witt, Oskar Außerer, Susanne Baier, Herbert Heidegger, Katja Icke, Oswald Mayr, Manfred Mitterer, Stephanie Roll, Gilbert Spizzo, Arthur Scherer, Christian Thuile, Anton Wieser, Lena Schützler

01.01.2015 | Clinical trial | Ausgabe 2/2015 Open Access

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

S. de Groot, L. G. M. Janssen, A. Charehbili, E. M. Dijkgraaf, V. T. H. B. M. Smit, L. W. Kessels, A. van Bochove, H. W. M. van Laarhoven, E. Meershoek-Klein Kranenbarg, A. E. van Leeuwen-Stok, C. J. H. van de Velde, H. Putter, J. W. R. Nortier, J. J. M. van der Hoeven, H. Pijl, J. R. Kroep

01.01.2015 | Epidemiology | Ausgabe 2/2015

Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study

Qingchao Qiu, Yinghao Su, Ying Zheng, Hui Cai, Shenghui Wu, Wei Lu, Wei Zheng, Xiao Ou Shu, Qiuyin Cai

01.01.2015 | Epidemiology | Ausgabe 2/2015

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer

Kimberly A. Bertrand, Bernard Rosner, A. Heather Eliassen, Susan E. Hankinson, Kathryn M. Rexrode, Walter Willett, Rulla M. Tamimi

01.01.2015 | Epidemiology | Ausgabe 2/2015

Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer

Anthony F. Yu, Nandini U. Yadav, Betty Y. Lung, Anne A. Eaton, Howard T. Thaler, Clifford A. Hudis, Chau T. Dang, Richard M. Steingart

01.01.2015 | Epidemiology | Ausgabe 2/2015

Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study

Lone Winther Lietzen, Deirdre Cronin-Fenton, Peer Christiansen, Henrik Toft Sørensen, Timothy L. Lash

01.01.2015 | Epidemiology | Ausgabe 2/2015

History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response

Louise Huzell, Mia Persson, Maria Simonsson, Andrea Markkula, Christian Ingvar, Carsten Rose, Helena Jernström

01.01.2015 | Epidemiology | Ausgabe 2/2015

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

Celine M. Vachon, Daniel J. Schaid, James N. Ingle, D. Lawrence Wickerham, Michiaki Kubo, Taisei Mushiroda, Matthew P. Goetz, Erin E. Carlson, Soonmyung Paik, Norman Wolmark, Yusuke Nakamura, Liewei Wang, Richard Weinshilboum, Fergus J. Couch

01.01.2015 | Epidemiology | Ausgabe 2/2015

Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis

María de Pedro, Sara Baeza, María-Teresa Escudero, Trinidad Dierssen-Sotos, Inés Gómez-Acebo, Marina Pollán, Javier Llorca

01.01.2015 | Epidemiology | Ausgabe 2/2015 Open Access

The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry

Ann J. Cloud, Ashley Thai, Yuyan Liao, Mary Beth Terry

01.01.2015 | Brief Report | Ausgabe 2/2015

Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry

Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, Helen Tsimiklis, Zhi L. Teo, Roger Li, Bernard J. Pope, Mary Beth Terry, Saundra S. Buys, Mary Daly, John L. Hopper, Ingrid Winship, David E. Goldgar, Daniel J. Park, Melissa C. Southey

01.01.2015 | Brief Report | Ausgabe 2/2015

Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin

Lior Z. Braunstein, Jane E. Brock, Yu-Hui Chen, Linh Truong, Andrea L. Russo, Nils D. Arvold, Jay R. Harris

01.01.2015 | Erratum | Ausgabe 2/2015

Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure

Suleiman Massarweh, Edward Romond, Esther P. Black, Emily Van Meter, Brent Shelton, Vera Kadamyan-Melkumian, Mark Stevens, Richard Elledge

01.01.2015 | Erratum | Ausgabe 2/2015

Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis

C. A. Drukker, S. G. Elias, M. V. Nijenhuis, J. Wesseling, H. Bartelink, P. Elkhuizen, B. Fowble, P. W. Whitworth, R. R. Patel, F. A. de Snoo, L. J. van’t Veer, P. D. Beitsch, E. J. Th. Rutgers

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.